Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 15,000 | $60.28 | $904,200.00 | -22.9% | → |
| 2026-01-02 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 1,798 | $62.62 | $112,584.77 | -1.8% | → |
| 2025-12-29 | Callos Andrew | EVP, Chief Commercial Officer | Sell | 1,809 | $62.44 | $112,953.96 | -3.4% | → |
| 2025-12-22 | WIERENGA WENDELL | Director | Sale+OE | 20,000 | $66.14 | $1,322,800.00 | -38.1% | → |
| 2025-12-16 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,200 | $61.24 | $134,728.00 | -1.6% | → |
| 2025-12-08 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 1,042 | $65.96 | $68,730.32 | -2.0% | → |
| 2025-12-05 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 52,486 | $65.95 | $3,461,451.70 | -50.9% | → |
| 2025-12-02 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,200 | $63.89 | $140,558.00 | -1.5% | → |
| 2025-12-02 | HENDERSON JOHN T | Director | Sale+OE | 8,750 | $63.90 | $559,125.00 | -10.5% | → |
| 2025-12-01 | Kaye Edward M. MD | Director | Sale+OE | 28,064 | $66.72 | $1,872,430.08 | -73.8% | → |
| 2025-12-01 | Harrington Robert Arthur | Director | Sell | 2,150 | $66.80 | $143,620.00 | -10.4% | → |
| 2025-11-19 | PARSHALL B LYNNE | Director | Sell | 5,000 | $64.73 | $323,650.00 | -17.9% | → |
| 2025-11-18 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,200 | $66.45 | $146,190.00 | -1.5% | → |
| 2025-11-11 | Kaye Edward M. MD | Director | Sale+OE | 5,175 | $65.08 | $336,789.00 | -34.2% | → |
| 2025-11-04 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,295 | $59.55 | $136,667.25 | -1.6% | → |
| 2025-10-30 | Blum Robert I | President & CEO | Sell | 5,000 | $62.86 | $314,300.00 | -1.4% | → |
| 2025-10-27 | WIERENGA WENDELL | Director | Sale+OE | 4,375 | $58.68 | $256,725.00 | -11.9% | → |
| 2025-10-21 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,105 | $58.22 | $122,553.10 | -1.5% | → |
| 2025-10-16 | Blum Robert I | President & CEO | Sell | 5,000 | $60.03 | $300,150.00 | -1.4% | → |
| 2025-10-07 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $60.56 | $121,120.00 | -1.4% | → |
| 2025-10-06 | Kaye Edward M. MD | Director | Sell | 6,757 | $60.00 | $405,420.00 | -40.9% | → |
| 2025-10-01 | Blum Robert I | President & CEO | Sell | 5,000 | $55.05 | $275,250.00 | -1.3% | → |
| 2025-09-30 | Kaye Edward M. MD | Director | Sell | 6,695 | $55.08 | $368,760.60 | -28.8% | → |
| 2025-09-23 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $49.28 | $98,560.00 | -1.4% | → |
| 2025-09-15 | Blum Robert I | President & CEO | Sell | 5,000 | $49.77 | $248,850.00 | -1.3% | → |
| 2025-09-09 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $51.29 | $102,580.00 | -1.4% | → |
| 2025-09-02 | Blum Robert I | President & CEO | Sell | 5,000 | $48.76 | $243,800.00 | -1.3% | → |
| 2025-09-02 | Harrington Robert Arthur | Director | Sell | 2,150 | $48.67 | $104,640.50 | -9.5% | → |
| 2025-09-02 | Kaye Edward M. MD | Director | Sell | 6,756 | $50.00 | $337,800.00 | -22.5% | → |
| 2025-08-19 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $38.31 | $76,620.00 | -1.4% | → |
| 2025-08-15 | Blum Robert I | President & CEO | Sell | 5,000 | $38.42 | $192,100.00 | -1.3% | → |
| 2025-08-05 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $36.34 | $72,680.00 | -1.4% | → |
| 2025-07-29 | Blum Robert I | President & CEO | Sell | 5,000 | $36.45 | $182,250.00 | -1.3% | → |
| 2025-07-22 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $37.47 | $74,940.00 | -1.4% | → |
| 2025-07-14 | Blum Robert I | President & CEO | Sell | 5,000 | $38.15 | $190,750.00 | -1.3% | → |
| 2025-07-08 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $33.76 | $67,520.00 | -1.4% | → |
| 2025-07-01 | Blum Robert I | President & CEO | Sell | 5,000 | $33.55 | $167,750.00 | -1.2% | → |
| 2025-06-17 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $32.91 | $65,820.00 | -1.4% | → |
| 2025-06-16 | Blum Robert I | President & CEO | Sell | 5,000 | $33.80 | $169,000.00 | -1.2% | → |
| 2025-06-05 | Kaye Edward M. MD | Director | Sell | 3,636 | $32.10 | $116,715.60 | -10.9% | → |
| 2025-06-05 | Callos Andrew | EVP, Chief Commercial Officer | Sell | 8,659 | $32.04 | $277,434.36 | -14.3% | → |
| 2025-06-03 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $31.88 | $63,760.00 | -1.4% | → |
| 2025-06-02 | Blum Robert I | President & CEO | Sell | 5,000 | $31.22 | $156,100.00 | -1.2% | → |
| 2025-05-20 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $31.98 | $63,960.00 | -1.4% | → |
| 2025-05-16 | Blum Robert I | President & CEO | Sell | 5,000 | $30.93 | $154,650.00 | -1.2% | → |
| 2025-05-15 | Bhanji Muna | Director | Sell | 1,454 | $29.73 | $43,227.42 | -5.8% | → |
| 2025-05-06 | Malik Fady Ibraham | EVP Research & Development | Sale+OE | 2,000 | $35.01 | $70,020.00 | -1.4% | → |
| 2025-05-05 | Callos Andrew | EVP, Chief Commercial Officer | Sell | 4,002 | $36.68 | $146,793.36 | -6.2% | → |
| 2025-04-29 | Blum Robert I | President & CEO | Sell | 5,000 | $40.96 | $204,800.00 | -1.2% | → |